Pharma Showers Key Oregon Lawmakers With Money
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The industry has given big bucks to U.S. Rep. Greg Walden, who chairs a powerful congressional committee, but has ignored Rep. Peter DeFazio, who is not on any committees that influence drug legislation.
Oregon’s congressional delegation includes members who are among the most courted by the nation’s pharmaceutical industry, and those who are among the most shunned, a new study shows, as the battle over sky-high U.S. prescription drug prices takes on a greater intensity.
